These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5492488)

  • 1. The half-life of factor XIII in vivo.
    Miloszewski K; Losowsky MS
    Br J Haematol; 1970 Dec; 19(6):685-90. PubMed ID: 5492488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Substitution treatment of factor XIII deficiency with a new factor XIII concentrate].
    Trobisch H; Egbring R
    Dtsch Med Wochenschr; 1972 Mar; 97(13):499-502. PubMed ID: 5011493
    [No Abstract]   [Full Text] [Related]  

  • 3. The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders.
    Lisman T; de Moerloose P
    Semin Thromb Hemost; 2016 Jun; 42(4):331-2. PubMed ID: 27232229
    [No Abstract]   [Full Text] [Related]  

  • 4. The half life of factor XIII in the management of inherited deficiency.
    Fear JD; Miloszewski KJ; Losowsky MS
    Thromb Haemost; 1983 Apr; 49(2):102-5. PubMed ID: 6868004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the action of factor XIII on the structure of fibrin in the normal and pathological states.
    Kleimenov AN; Rozenfel'd MA; Piruzyan LA; Titova MI; Shimkevich LL
    Biol Bull Acad Sci USSR; 1978; 5(5):610-4. PubMed ID: 754811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models.
    Nagashima F; Inoue S; Koami H; Miike T; Sakamoto Y; Kai K
    J Trauma Acute Care Surg; 2018 Sep; 85(3):588-597. PubMed ID: 29851904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
    Nugent DJ
    Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 10. Substitution of factor XIII: a therapeutic approach to ulcerative colitis.
    Lorenz R; Heinmüller M; Classen M; Tornieporth N; Gain T
    Haemostasis; 1991; 21(1):5-9. PubMed ID: 1677916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
    Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
    Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of factor XIII on bleeding in coronary surgery.
    Gödje O; Haushofer M; Lamm P; Reichart B
    Thorac Cardiovasc Surg; 1998 Oct; 46(5):263-7. PubMed ID: 9885116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient whose factor XIII level was decreased by double filtrate plasmapheresis and successfully recovered by infusion of factor XIII concentrate.
    Hanafusa N; Aozasa N; Fujita T
    Ther Apher Dial; 2010 Aug; 14(4):432-3. PubMed ID: 20649765
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of factor XIII deficiency with cryoprecipitate.
    Amris CJ; Hilden M
    Thromb Diath Haemorrh; 1968 Dec; 20(3):528-33. PubMed ID: 5710469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postoperative complications due to acquired factor XIII deficiency].
    Thies HA; Busch H; Koch G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):135-40. PubMed ID: 4173875
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen Aarhus and factor XIII induced polymerization and gel formation.
    Hessel B; Adamson L; Procyk R; Therkildsen L; Stenbjerg S; Blombäck B
    Br J Haematol; 1987 Jul; 66(3):355-61. PubMed ID: 3620354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor XIII in the treatment of hemophilia A.
    Rea CJ; Foley JH; Sørensen B
    N Engl J Med; 2012 Jan; 366(3):281-3. PubMed ID: 22256823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic action of coagulation factor XIII in scleroderma. 20 cases].
    Thivolet J; Perrot H; Meunier F; Bouchet B
    Nouv Presse Med; 1975 Nov; 4(39):2779-82. PubMed ID: 1105424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
    Tahlan A; Ahluwalia J
    Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.